Intermittent claudication: new targets for drug development.
about
Mitochondrial Regulation of the Muscle Microenvironment in Critical Limb IschemiaPeripheral artery disease, redox signaling, oxidative stress - Basic and clinical aspectsRisk of Peripheral Artery Disease in Patients With Carbon Monoxide Poisoning: A Population-Based Retrospective Cohort StudyBlood pressure and calf muscle oxygen extraction during plantar flexion exercise in peripheral artery disease.Change of walking distance in intermittent claudication: impact on inflammation, oxidative stress and mononuclear cells: a pilot study.Toxicity of a novel therapeutic agent targeting mitochondrial complex I.
P2860
Intermittent claudication: new targets for drug development.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Intermittent claudication: new targets for drug development.
@en
type
label
Intermittent claudication: new targets for drug development.
@en
prefLabel
Intermittent claudication: new targets for drug development.
@en
P2860
P1433
P1476
Intermittent claudication: new targets for drug development.
@en
P2093
Eric P Brass
P2860
P2888
P304
P356
10.1007/S40265-013-0078-3
P577
2013-07-01T00:00:00Z
P6179
1044433517